ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.509,87
-0,49%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,53%
Euro vs US Dollar
1,08993
0,00%
Bitcoin
63.455,69
-2,15%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) News

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VRDN
DatumZeitQuelleÜberschriftSymbolFirma
30/11/202114h00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
18/11/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRDNViridian Therapeutics Inc
15/11/202113h00GlobeNewswire Inc.Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)NASDAQ:VRDNViridian Therapeutics Inc
08/11/202115h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
04/11/202121h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
04/11/202121h05GlobeNewswire Inc.Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
03/11/202121h05GlobeNewswire Inc.Viridian Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:VRDNViridian Therapeutics Inc
28/10/202112h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
14/10/202114h00GlobeNewswire Inc.Viridian Therapeutics Submits Investigational New Drug Application for VRDN-001, an IGF-1R antibody for the treatment of Thyroid Eye Disease, to the U.S. Food and Drug AdministrationNASDAQ:VRDNViridian Therapeutics Inc
08/10/202114h37Edgar (US Regulatory)Schedule 13gNASDAQ:VRDNViridian Therapeutics Inc
05/10/202100h38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
30/09/202122h31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
30/09/202114h06GlobeNewswire Inc.Viridian Therapeutics to Present Preclinical Data on VRDN-001 and VRDN-002 at the 90th Annual Meeting of the American Thyroid AssociationNASDAQ:VRDNViridian Therapeutics Inc
29/09/202115h32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRDNViridian Therapeutics Inc
29/09/202112h05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRDNViridian Therapeutics Inc
29/09/202101h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
24/09/202123h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
23/09/202122h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
23/09/202122h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VRDNViridian Therapeutics Inc
23/09/202122h01GlobeNewswire Inc.Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters' Option to Purchase Additional SharesNASDAQ:VRDNViridian Therapeutics Inc
22/09/202123h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRDNViridian Therapeutics Inc
21/09/202106h22GlobeNewswire Inc.Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred StockNASDAQ:VRDNViridian Therapeutics Inc
20/09/202122h01GlobeNewswire Inc.Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred StockNASDAQ:VRDNViridian Therapeutics Inc
10/09/202112h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
26/08/202119h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
11/08/202113h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
11/08/202113h00GlobeNewswire Inc.Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
05/08/202114h30GlobeNewswire Inc.Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual ConferenceNASDAQ:VRDNViridian Therapeutics Inc
27/07/202122h55Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
27/07/202122h14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
DBI
MDAX
MDAX
DBI
TDXP
Tec DAX
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
FX
EURGBP
Euro vs Sterling
TG
CBK
Commerzbank
TG
D7G
Nel ASA
TG
ALV
Allianz
TG
LHA
Deutsche Lufthansa
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten